Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques-Eric Gottenberg

Showing results (131-140 of 311) with videos related to

Pageof 32
Sort By:
Annals of the Rheumatic Diseases|December 25, 2012
Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issueClaudio Vitali, Hendrika Bootsma, Simon J Bowman, et al.
Annals of the Rheumatic Diseases|September 5, 2006
Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndromeRaphaèle Seror, Christelle Sordet, Loic Guillevin, et al.
Journal of Clinical Medicine|April 13, 2024
Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR CohortRenaud Felten, Thibaut Fabacher, Nathanaël Sedmak, et al.
The Journal of Rheumatology|June 17, 2011
Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French Autoimmunity and Rituximab registryBrigitte Bader-Meunier, Hélène Decaluwe, Christine Barnerias, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 6, 2013
Targeting the splicing of mRNA in autoimmune diseases: BAFF inhibition in Sjögren's syndrome as a proof of conceptN Roescher, J L Vosters, G Alsaleh, et al.
Rheumatology International|June 24, 2021
Revisiting the JOQUER trial: stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquineAlexis Collins, Dennis Lendrem, James Wason, et al.
Rheumatology (Oxford, England)|March 4, 2023
Identification of new candidate drugs for primary Sjögren's syndrome using a drug repurposing transcriptomic approachRenaud Felten, Tao Ye, Cedric Schleiss, et al.
Rheumatology and Therapy|September 23, 2025
Real-World Assessment of Systemic Disease Activity in Seropositive and Seronegative Patients with Sjögren's Disease and Association with Patient-Reported OutcomesJacques-Eric Gottenberg, Raphaele Seror, Nicola Massey, et al.
Seminars in Arthritis and Rheumatism|September 18, 2016
Systemic capillary leak syndrome and autoimmune diseases: A case seriesAurélien Guffroy, Benjamin Dervieux, Simon Gravier, et al.
BMC Medical Education|August 30, 2025
Advancing medical training with augmented reality and haptic feedback simulator: outcomes of a randomized controlled trial on lumbar punctureRenaud Felten, Kevin Bigaut, Thomas Wirth, et al.
Pageof 32

Showing results (131-140 of 311) with videos related to

Sort By:
Pageof 32
Annals of the Rheumatic Diseases|December 25, 2012
Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issueClaudio Vitali, Hendrika Bootsma, Simon J Bowman, et al.
Annals of the Rheumatic Diseases|September 5, 2006
Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndromeRaphaèle Seror, Christelle Sordet, Loic Guillevin, et al.
Journal of Clinical Medicine|April 13, 2024
Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR CohortRenaud Felten, Thibaut Fabacher, Nathanaël Sedmak, et al.
The Journal of Rheumatology|June 17, 2011
Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French Autoimmunity and Rituximab registryBrigitte Bader-Meunier, Hélène Decaluwe, Christine Barnerias, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 6, 2013
Targeting the splicing of mRNA in autoimmune diseases: BAFF inhibition in Sjögren's syndrome as a proof of conceptN Roescher, J L Vosters, G Alsaleh, et al.
Rheumatology International|June 24, 2021
Revisiting the JOQUER trial: stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquineAlexis Collins, Dennis Lendrem, James Wason, et al.
Rheumatology (Oxford, England)|March 4, 2023
Identification of new candidate drugs for primary Sjögren's syndrome using a drug repurposing transcriptomic approachRenaud Felten, Tao Ye, Cedric Schleiss, et al.
Rheumatology and Therapy|September 23, 2025
Real-World Assessment of Systemic Disease Activity in Seropositive and Seronegative Patients with Sjögren's Disease and Association with Patient-Reported OutcomesJacques-Eric Gottenberg, Raphaele Seror, Nicola Massey, et al.
Seminars in Arthritis and Rheumatism|September 18, 2016
Systemic capillary leak syndrome and autoimmune diseases: A case seriesAurélien Guffroy, Benjamin Dervieux, Simon Gravier, et al.
BMC Medical Education|August 30, 2025
Advancing medical training with augmented reality and haptic feedback simulator: outcomes of a randomized controlled trial on lumbar punctureRenaud Felten, Kevin Bigaut, Thomas Wirth, et al.
Pageof 32